ORPHA:2038
Pulmonary arteriovenous malformation
Also known as: PAVM
Publications
3,551
90.1th percentile
Trials
2
Interventional, condition-specific
Researchers
1,009
Distinct authors in sample
Gene link
CIAO3
Limited
Readiness
4/6
Stages with a signal
Clinical definition (Orphanet)
An aberrant communication between one or more pulmonary arteries and one or more pulmonary veins leading to an anatomic intrapulmonary right-to-left shunt.
How rare: 1-9 / 100 000 — about one to nine people per hundred thousand.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0009930
- MeSH:C562404
- OMIM:265140
- NCIT:C99029
Additional Mondo synonyms (5)
arteriovenous fistula of pulmonary vessels · pulmonary AV fistula · pulmonary arteriovenous fistula · pulmonary arteriovenous malformation · pulmonary arteriovenous malformation (disease)
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
4/6 stages with a signal
An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.
- Gene identifiedPresent
Limited — CIAO3
- LiteraturePresent
3,551 matched papers (1,782 in last 10 years) Source
- Phenotype characterisedPresent
32 HPO annotations (e.g. Pulmonary arteriovenous fistulas; Clubbing of fingers; Cyanosis) Source
- Animal modelNot found
No Alliance genotype “model of” associations via Monarch for these Mondo IDs
- Orphan designationNot found
No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source
- Interventional trialPresent
2 matched on ClinicalTrials.gov (1 recruiting in sample)
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Possibly — only limited evidence so far for CIAO3.
GenCC classification: Limited.
Phenotypes (Monarch / HPO)
32
Associated phenotypes · MONDO:0009930
- Pulmonary arteriovenous fistulas
- Clubbing of fingers
- Cyanosis
- Clubbing of toes
- Telangiectasia
Showing 5 of 32 — open Monarch for the full list.
Animal models (Monarch / Alliance)
None returned for this Mondo ID. Empty here is not proof that no model organism work exists under another name or gene.
Monarch fetch 2026-07-29
Therapies
Designations, candidates, and chemicals
FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.
Orphan designation (FDA · EMA)
No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.
Open Targets candidates
No drugs or clinical candidates returned for this Mondo ID on Open Targets.
CTD chemicals (MyDisease.info)
No CTD chemical associations returned for this Mondo ID.
Literature
Is anyone studying this?
3,551
3,551 papers have been published on this condition. That is a real research literature — still far smaller than common diseases (breast cancer: over 700,000 papers). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.
3,551 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).
1,782 in the last 10 years · medium confidence · 90.1th percentile (publications denominator)
Phrase hits: 3,504 · MeSH hits: 0
Who's working on it?
1,009
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.
- 01Ma X5 papers · 2026
Department of Radiology, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, No. 507 Zhengmin Road, Shanghai, 200433, China.
Papers in Europe PMC - 02Li X4 papers · 2026
Department of Cardiology, Zhongshan Hospital of Traditional Chinese Medicine, Zhongshan, 528400, Guangdong, China.
Papers in Europe PMC - 03Suzuki T4 papers · 2026
Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.
Papers in Europe PMC - 04Chen H3 papers · 2026
Department of Neurology, University of Maryland Medical Center, Baltimore, MD 21201, USA; Neurosurgery, University of Maryland Medical Center, Baltimore, MD 21201, USA.
Papers in Europe PMC - 05Chen J3 papers · 2026
Department of Infectious Diseases, The Fifth Affiliated Hospital of Wenzhou Medical University, Lishui Central Hospital, Lishui, 323000, China.
Papers in Europe PMC - 06Chen S3 papers · 2026
Department of Pediatric Cardiology, Xinhua Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, 1665 Kongjiang Road, Shanghai 200092, China.
Papers in Europe PMC - 07Hessels J3 papers · 2026
Department of Pulmonology, St. Antonius Hospital, Nieuwegein, the Netherlands. Electronic address: j.hessels@antoniusziekenhuis.nl.
Papers in Europe PMC - 08Li J3 papers · 2026
Cardiac Ultrasound Room of Cardiac Center, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.
Papers in Europe PMC - 09Post MC3 papers · 2026
Department of Cardiology, University Medical Centre Utrecht, Utrecht, The Netherlands; Department of Cardiology, St. Antonius Hospital, Nieuwegein, the Netherlands.
Papers in Europe PMC - 10Sugiura T3 papers · 2026
Department of Respiratory Medicine, Graduate School of Medicine, Chiba University, Japan.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
2
interventional trials for this specific condition
2 interventional trials matched this specific condition name; 1 currently recruiting in our sample.
Data as of 11 September 2026 · last trial check 28 July 2026
2 interventional trials — more than 77.2% of diseases in the trials denominator have none at all (5501 of 7126; this disease is at the 84.5th percentile).
medium confidence · 84.5th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
2 interventional trials matched after quoted-phrase search and title/condition post-filter.
- NCT07414446·RECRUITING·Non-Invasive Detection of Pulmonary Right-to-Left Shunts Using the SONAS Ultrasound Device
Not reviewed·Conditions: Hereditary Haemorrhagic Telangiectasia · PFO - Patent Foramen Ovale · Pulmonary Arteriovenous Malformation·Matched via name phrase
Observational and natural-history studies
7 observational studies match this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.
Recruiting or not-yet-recruiting
- NCT07525518·ENROLLING BY INVITATION·Okami Medical ALPHA Registry
Not reviewed·Conditions: Arterial Bleed · Pulmonary Arteriovenous Malformation · Embolization · Hemorrhage·Matched via name phrase
- NCT06099015·RECRUITING·Cera™ Vascular Plug System Post-Market Clinical Follow-Up
Not reviewed·Conditions: Aneurysm · Endoleak · Pulmonary Arteriovenous Malformation · Portal Hypertension·Matched via name phrase
- NCT07519876·RECRUITING·Pulmonary Embolism and Right-to-Left Shunts
Not reviewed·Conditions: Pulmonary Embolism (PE) · Right-to-Left Shunt · Stroke · Atrial Septal Defects·Matched via name phrase
Other registries (secondary)
Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.
raw 6 · after dedupe 6 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 6 · dropped 0 · fetched 2026-07-29
Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri
No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).
Uncertain / not reviewed (6)
- isrctn·ISRCTN16705062·Recruiting·The use of aspirin or clopidogrel for people who survive stroke due to bleeding in the brain
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN15383301·No longer recruiting·Mannitol for stopping or preventing brain swelling (cerebral oedema) after stroke from bleeding in the brain (intracerebral haemorrhage): a feasibility study
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN13376195·No longer recruiting·A study to evaluate the safety, processing by the body and response of the body to tenecteplase in adults with acute ischemic stroke
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN78818544·No longer recruiting·Systemic therapy in advanced or metastatic prostate cancer: evaluation of drug efficacy
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN14164179·Stopped·A study to test the safety and effectiveness of using mutant pro-urokinase and low-dose alteplase to unblock blood vessels in heart attack patients before receiving treatment at a hospital with PCI capability
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN18275480·Recruiting·Heart failure in patients with advanced chronic kidney disease
skipped — LLM skipped (--skip-llm)
Where to find support
Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.
Orphanet entry for Pulmonary arteriovenous malformation — check Associations / patient organisations on that page.
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
("Pulmonary arteriovenous malformation" OR "arteriovenous fistula of pulmonary vessels" OR "arteriovenous fistula of the pulmonary vessels" OR "pulmonary AV fistula" OR "pulmonary arteriovenous fistula" OR "pulmonary arteriovenous malformation (disease)") OR ("CIAO3" OR "CIAO3 syndrome" OR "CIAO3-related")ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Pulmonary arteriovenous malformation" OR "arteriovenous fistula of pulmonary vessels" OR "arteriovenous fistula of the pulmonary vessels" OR "pulmonary AV fistula" OR "pulmonary arteriovenous fistula" OR "pulmonary arteriovenous malformation (disease)"
Interventional trials matched via: phrase (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).
Study-type breakdown: 2 interventional · 7 observational · 0 expanded access. Only interventional studies enter the trial headline.
Query health: ok — strategies attempted: phrase; with hits: phrase
Run this search on ClinicalTrials.gov
Synonyms dropped by stoplist: PAVM
Confidence reasoning
- Preferred label is multi-word and distinctive
- 1 synonym(s) dropped by stoplist (may under-count)
- No label/synonym collisions with other diseases in this corpus
Ingested 2026-07-26T18:50:56.784Z
